{"brief_title": "Preference of Rheumatoid Arthritis (RA) Patients of Enbrel\u00ae (Etanercept) Auto-Injector Versus Enbrel\u00ae Pre-Filled Syringes", "brief_summary": "The purpose of this study is to determine the preference of RA patients for the new Enbrel\u00ae (etanercept) pre-filled syringe in patients who are already taking Enbrel\u00ae.", "condition": ["Rheumatoid Arthritis"], "intervention_type": ["Drug"], "intervention_name": ["Etanercept"], "criteria": "Inclusion Criteria: - Have established RA diagnosis as determined by ACR criteria - Be current user of etanercept-lyophilized preparation for at least 4 consecutive weeks of etanercept dosing on either a once weekly or twice weekly regimen - Subject must be able to self inject - Give written informed consent Exclusion Criteria: - Subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) - Subject of childbearing potential is pregnant (e.g., positive HCG test) or is breast-feeding - Elective surgery is planned during study period - Subjects allergic to latex", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Rheumatology", "mesh_term": ["Arthritis", "Arthritis, Rheumatoid", "Etanercept"], "id": "NCT00094341"}